SELLAS Life Sciences Group, Inc. (SLS)
3.98
+0.14
(+3.65%)
USD |
NASDAQ |
Jan 16, 16:00
3.93
-0.05
(-1.26%)
After-Hours: 04:21
SELLAS Life Sciences Group Total Assets (Quarterly): 51.56M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| GT Biopharma, Inc. | 4.321M |
| Amicus Therapeutics, Inc. | 868.81M |
| Geron Corp. | 567.38M |
| Vanda Pharmaceuticals, Inc. | 601.14M |
| ADMA Biologics, Inc. | 568.69M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.925M |
| Shareholders Equity (Quarterly) | 45.63M |
| Debt to Equity Ratio | 0.0131 |
| Current Ratio | 8.279 |
| Net Debt Paydown Yield | 0.01% |